Variability in viscoelastic haemostatic assay in major haemorrhage protocols: A unified approach or mixed signals?
Transfusion Medicine · 2025-10 · 35 (5) · 476-485
DOI: 10.1111/tme.70003 ↗Abstract
Abstract Background and Objectives Viscoelastic haemostatic assays (VHA) are part of patient blood management (PBM) for bleeding, associated with reduced transfusions. This study reviewed all major haemorrhage protocols (MHPs) using VHA in Queensland, Australia, and assessed variability. Methods VHA platforms in Queensland Health include rotational thromboelastometry (ROTEM® Sigma) and thromboelastography (TEG 6 s). PBM guidelines were searched for VHA‐guided MHPs. Outcomes included viscoelastic thresholds and transfusion recommendations. Results Nineteen hospitals used VHA: sixteen with ROTEM and three with TEG. Among hospitals with ROTEM, fibrinolysis was assessed first in 13 algorithms, primarily using FIBTEM flat‐line ( n = 6) or ML >5% ( n = 5). Fibrinogen thresholds were FIBTEM A5
EUVIMED